Monday, June 7, 2021

IN8bio Completes Treatment of First Cohort in Phase 1 Clinical Trial with Gamma Delta T-Cell ...

“Our DeltEx DRI platform combines the advantages of gamma delta T-cells with proprietary genetic engineering and next-generation cell therapy ...
https://www.google.com/url?rct=j&sa=t&url=https://www.globenewswire.com/news-release/2021/06/07/2242603/0/en/IN8bio-Completes-Treatment-of-First-Cohort-in-Phase-1-Clinical-Trial-with-Gamma-Delta-T-Cell-Therapy-in-Patients-with-Newly-Diagnosed-Glioblastoma-Multiforme.html&ct=ga&cd=CAIyGjg0YzkwMzEwZTQwYzQxNjA6Y29tOmVuOlVT&usg=AFQjCNHtD3B8crk4t12LjVUzts-X3SKklg
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...